A new year, a continued commitment to enhancing patient access to quality care

As we step into 2025, we reaffirm our dedication to making a meaningful difference in patient’s lives. Whether facilitating innovative solutions for hospitals or delivering care directly to patients, our shared commitment to patient wellbeing shapes our strategic direction and informs every aspect of our operations. Patients inspire us to continuously strive for excellence, and…

Read More

Leadership Changes at Ergéa Group

Ergéa Group appoints Dr. Michael Thorwarth as Group CEO; Dr. Guglielmo Brayda di Soleto transitions to Co-Chairman of Ergéa Group. As of September 16th  2024,  Dr. Michael Thorwarth, currently CEO of Ergéa Deutschland, has been appointed as the new Group CEO. He will continue and expand Ergéa’s collaborative leadership model and work in partnership with…

Read More

Ergéa Group establishes Medical Scientific Committee to drive innovation and enhance quality

Ergéa Group proudly announces the formation of its new Medical Scientific Committee, a diverse and experienced team of experts in oncology, radiation therapy, radiology, nuclear medicine, clinical engineering and technology assessment. The Medical Scientific Committee will convene on a regular basis to provide responses to any questions arising from the group’s activities, with a strong…

Read More